Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 25, 2024 09:14 ET | Source: Research and Markets

Acute Pancreatitis Global Market Report 2024: Market to Surge to $7.41 Billion by 2028, Driven by Technological Advances and Growing Health Concerns - Long-term Forecast to 2033

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Acute Pancreatitis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The latest acute pancreatitis market...
May 15, 2023 07:00 ET | Source: First Wave BioPharma, Inc.

First Wave BioPharma CEO James Sapirstein to Present at 2023 BIO International Conference

BOCA RATON, Fla., May 15, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ: FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
May 11, 2023 07:00 ET | Source: First Wave BioPharma, Inc.

First Wave BioPharma Completes Patient Screening For Phase 2 Span Adrulipase Clinical Trial in Cystic Fibrosis

Top line data read-out on track for July 2023 BOCA RATON, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. ("First Wave BioPharma" or the “Company”) (NASDAQ: FWBI), a...
August 23, 2021 11:20 ET | Source: Ariel Precision Medicine

Ariel Precision Medicine Expands Executive Team with Appointment of Dr. David C. Whitcomb as Chief Scientific Officer

Pittsburgh, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held biotechnology company developing innovative solutions for complex chronic disease, announced the...
November 24, 2020 08:17 ET | Source: InvestorBrandNetwork (IBN)

InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast Featuring AzurRx Biopharma Inc. President & CEO James Sapirstein

LOS ANGELES, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
June 15, 2020 08:00 ET | Source: Ariel Precision Medicine

Mission Cure Holdings, Path BioAnalytics and Ariel Precision Medicine, Launch Unique Research Alliance to Advance Treatments for Pancreatitis

New York; Chapel Hill, NC; Pittsburgh, June 15, 2020 (GLOBE NEWSWIRE) -- Mission Cure Holdings, LLC, Path BioAnalytics, Inc. and Ariel Precision Medicine, Inc. jointly announced the creation of a...
March 19, 2019 08:00 ET | Source: Ariel Precision Medicine

Ariel Precision Medicine Named Life Sciences PA Emerging Company of the Year

Pittsburgh, March 19, 2019 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held, clinically integrated, genomics and health technology company developing innovative solutions for...
September 24, 2018 12:10 ET | Source: Ariel Precision Medicine

Ariel Precision Medicine Inc. Launches New Genomic Tools for Early Diagnosis, Personalized Management of Pancreatic Diseases

Pittsburgh, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Ariel Precision Medicine, Inc., a privately held integrated genomics and digital health company developing innovative solutions for complex chronic...